Case Studies

CarboMet - Case Study - The Heparin Contamination Crisis

Case Study 1 – The Heparin contamination crisis (2008)

Heparin is a polysaccharide that interacts with antithrombin in blood and is widely used in the clinic as an injectable anticoagulant, isolated from natural sources. READ MORE

CarboMet - Case Study - Erythropoietin (EPO)

Case Study 2 – Erythropoietin (EPO)

EPO is a glycoprotein hormone that stimulates the production of red blood cells and is used as a therapeutic agent for the treatment of anaemia. READ MORE

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 737395.

CarboMet News

CarboMet on Twitter

CarboMet on LinkedIn

CarboMet on LinkedIn